Autolus Therapeutics (AUTL) Other Non-Current Assets (2018 - 2025)

Autolus Therapeutics (AUTL) has reported Other Non-Current Assets for 8 consecutive years, with $1.0 million the latest figure, recorded in Q4 2025.

• Quarterly Other Non-Current Assets rose 7.17% year-over-year to $1.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.0 million (up 7.17% YoY) and the FY2025 annual result came in at $1.0 million, up 7.17% from the prior year.
• Other Non-Current Assets steadied at $1.0 million in Q4 2025 per AUTL's latest filing, from $1.0 million in the prior quarter.
• Over the last five years, Other Non-Current Assets for AUTL reached as high as $5.3 million in Q2 2025 and fell as low as $943000.0 in Q3 2023.
• A 5-year average of $1.7 million and a median of $1.8 million in 2021 frame the typical range for Other Non-Current Assets.
• Annual changes were most pronounced in 2023 — Other Non-Current Assets slumped 54.83% — and 2025, when it jumped 438.18%.
• Year by year, Other Non-Current Assets stood at $2.4 million in 2021, then slipped by 7.87% to $2.2 million in 2022, then slumped by 54.83% to $983000.0 in 2023, then decreased by 2.03% to $963000.0 in 2024, then grew by 7.17% to $1.0 million in 2025.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $1.0 million, $1.0 million, and $5.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.